期刊文献+

^(18)F-FDG PET-CT与^(99m)Tc-MDP全身显像对肺癌骨转移癌诊断的对比研究 被引量:10

Comparison of ^(18)F-FDG PET-CT and ^(99m)Tc-MDP bone scintigraphy in detection of bone metastases of lung cancer
下载PDF
导出
摘要 目的:对比研究18F-FDGPET-CT全身显像与99mTc-MDP全身骨骼显像对肺癌骨转移诊断的价值。方法:回顾性研究49例病理证实为肺癌的患者,男28例,女21例,平均年龄(58.9±10.8)岁,所有患者均于10天内分别行18F-FDGPET-CT全身显像与99mTc-MDP全身骨显像,最终骨转移癌诊断结果由手术病理、MR检查或临床随访半年以上病灶范围扩大或加重证实。结果:49例患者18F-FDGPET-CT与99mTc-MDP全身显像共检出异常病灶259处,其中被证实为转移灶228处,31处为良性病灶。18F-FDGPET-CT和99mTc-MDPSPECT诊断骨转移癌的灵敏度为90.8%和56.6%,特异性为93.5%和45.2%,准确性为91.1%和55.2%。结论:18F-FDGPET-CT全身显像对肺癌骨转移诊断的灵敏度、特异性及准确性均高于99mTc-MDP全身骨显像。 Objective: To compare the diagnostic value of ^18F-FDG PET-CT and ^99mTc-MDP bone scintigraphy for the detection of bone metastases in patients with lung cancer. Methods: We examined 49 patients, 28 men, 21 women with lung cancer, mean age (58.9±10.8)years. All patients underwent both whole-body ISF-FDG PET-CT and ^99mTc-MDP bone scintigraphy within 10 days. Bone metastases were verified either by pathological results or MR findings or follow-up more than half a year. Results: Bone metastases were confirmed in 228 of the 259 foci. The sensitivity for bone metastases using ^18F-FDG PET-CT and ^99mTc-MDP as 90.8% and 56.6% respectively, the specificity was 93.5% and 45.2% respectively. The accuracy was 91.1% and 55.2% respectively. Conclusion: The specificity and the overall accuracy of ^18F-FDG PET-CT for the diagnosis of bone metastases in patients with lung cancer are higher than those of ^99mTc-MDP bone scintigraphy.
出处 《中国临床医学影像杂志》 CAS 北大核心 2009年第5期323-326,330,共5页 Journal of China Clinic Medical Imaging
关键词 肺肿瘤 肿瘤转移 骨肿瘤 正电子发射断层显像术 体层摄影术 发射型计算机 单光子 Lung neoplasms Neoplasm metastasis Bone neoplasms Positron-emission tomography Tomograpby, emission-computed, single-photon
  • 相关文献

参考文献11

二级参考文献38

  • 1李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:226
  • 2李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 3Jensen OM, Esteve J, Moller H, et al. Cancer in the European Community and its member states. Eur J Cancer, 1990, 26(11-12): 1167-1256. Erratum in: Eur J Cancer, 1991,27 (12):1717. 被引量:1
  • 4European Network of Cancer Registries (ENCR). (2001) EURO CIM version 4. 0. European Incidence Database V2. 3. Lyon:IARC Press,2001. 被引量:1
  • 5Bray F, Sankila R, Ferlay J, et al. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer,2002,38(1): 99-166. 被引量:1
  • 6Yang L, Parkin DM, Ferlay J, et al. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev, 2005,14(1): 243-250. 被引量:1
  • 7International Agency for Research on Cancer. IARC monographs on the Tobacco Smoke and Involuntary Smoking (Vol. 83). Lyon:IARC Press,2004. 被引量:1
  • 8Liu BQ, Peto R, Chen ZM, et al. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ,1998,317(7170) : 1411-1422. 被引量:1
  • 9Clinical Trial Service Unit, Oxford University. Emerging Tobacco Hazards in China. http:∥rum. ctsu. ox. ac. uk/tobacco. 被引量:1
  • 10Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide, Version 2. 0. IARC CancerBase No. 5. Lyon: IARC Press,2004. 被引量:1

共引文献174

同被引文献149

引证文献10

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部